Skip to content

Medical Abortion Self-Confirmation (MASC)

Medication Abortion Self-Confirmation (MASC): Comparison of Two Home Pregnancy Tests as an Alternative to Office Follow-up

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03148587
Acronym
MASC
Enrollment
88
Registered
2017-05-11
Start date
2017-05-01
Completion date
2018-05-31
Last updated
2019-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical Abortion

Keywords

abortion, medical abortion, mifepristone, pregnancy test

Brief summary

This study aims to investigate the ability of participants to perform and accurately interpret the multi-level pregnancy test and the low sensitivity pregnancy test following medication abortion, without routine provider contact.

Interventions

BEHAVIORALSelf-assessment: MLPT

Patients enrolled in the study will self-assess the outcomes of their medical abortion using the multi-level pregnancy test.

BEHAVIORALSelf-assessment: LSPT

Patients enrolled in the study will self-assess the outcomes of their medical abortion using the low sensitivity pregnancy test.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Gestational age of less than or equal to 63 days * English speaking * Determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria * In the judgement of the site investigator, she is capable of giving informed consent and she has signed the study informed consent or assent form

Exclusion criteria

* Allergy to mifepristone and/or misoprostol * Non-english speaking * Inability to access internet

Design outcomes

Primary

MeasureTime frame
Correct interpretation of pregnancy test4 weeks after taking medication abortion medication, mifepristone

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026